Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-02-14 10:06 am Sale | 13G | LA JOLLA PHARMACEUTICAL CO LJPC | RTW INVESTMENTS LP | 0 0.000% | -2,590,932 (Position Closed) | View |
2022-08-29 12:30 pm Sale | 13D | LA JOLLA PHARMACEUTICAL CO LJPC | GARDNER LEWIS ASSET MANAGEMENT L P | 0 0.000% | -1,504,791 (Position Closed) | View |
2022-08-29 12:07 pm Purchase | 13D | LA JOLLA PHARMACEUTICAL CO LJPC | GARDNER LEWIS ASSET MANAGEMENT L P | 1,504,791 6.000% | 1,504,791 (New Position) | View |
2022-08-24 4:00 pm Sale | 13D | LA JOLLA PHARMACEUTICAL CO LJPC | TANG CAPITAL PARTNERS LP | 0 0.000% | -9,959,934 (Position Closed) | View |
2022-07-11 6:15 pm Unchanged | 13D | LA JOLLA PHARMACEUTICAL CO LJPC | TANG CAPITAL PARTNERS LP | 9,959,934 39.800% | 0 (Unchanged) | View |
2022-02-14 09:26 am Purchase | 13G | LA JOLLA PHARMACEUTICAL CO LJPC | RTW INVESTMENTS LP | 2,590,932 9.300% | 193,554 (+8.07%) | View |
2021-12-02 08:30 am Sale | 13D | LA JOLLA PHARMACEUTICAL CO LJPC | TANG CAPITAL PARTNERS LP | 9,959,934 36.000% | -166,270 (-1.64%) | View |
2021-07-12 08:29 am Sale | 13G | LA JOLLA PHARMACEUTICAL CO LJPC | BlackRock Inc. BLK | 384,695 1.400% | -1,092,804 (-73.96%) | View |
2021-05-27 06:03 am Purchase | 13D | LA JOLLA PHARMACEUTICAL CO LJPC | TANG CAPITAL PARTNERS LP | 10,126,204 36.800% | 410,714 (+4.23%) | View |
2021-02-12 09:26 am Sale | 13G | LA JOLLA PHARMACEUTICAL CO LJPC | RTW INVESTMENTS LP | 2,397,378 8.750% | -153,642 (-6.02%) | View |
2021-01-29 5:23 pm Sale | 13G | LA JOLLA PHARMACEUTICAL CO LJPC | BlackRock Inc. BLK | 1,477,499 5.400% | -96,837 (-6.15%) | View |
2021-01-04 11:15 am Sale | 13G | LA JOLLA PHARMACEUTICAL CO LJPC | Broadfin Capital LLC | 0 0.000% | -2,688,068 (Position Closed) | View |
2020-09-11 06:02 am Purchase | 13D | LA JOLLA PHARMACEUTICAL CO LJPC | TANG CAPITAL PARTNERS LP | 9,715,490 35.400% | 278,369 (+2.95%) | View |
2020-08-18 06:05 am Purchase | 13D | LA JOLLA PHARMACEUTICAL CO LJPC | TANG CAPITAL PARTNERS LP | 9,437,121 34.400% | 431,647 (+4.79%) | View |
2020-07-29 5:18 pm Purchase | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH | LA JOLLA PHARMACEUTICAL CO LJPC | 7,263,236 100.000% | 6,178,236 (+569.42%) | View |
2020-06-30 5:37 pm Unchanged | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH | LA JOLLA PHARMACEUTICAL CO LJPC | 1,085,000 14.900% | 0 (Unchanged) | View |
2020-06-25 9:58 pm Unchanged | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH | LA JOLLA PHARMACEUTICAL CO LJPC | 1,085,000 14.900% | 0 (Unchanged) | View |
2020-06-22 5:17 pm Purchase | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH | LA JOLLA PHARMACEUTICAL CO LJPC | 1,085,000 14.900% | 1,085,000 (New Position) | View |
2020-06-05 06:04 am Purchase | 13D | LA JOLLA PHARMACEUTICAL CO LJPC | TANG CAPITAL PARTNERS LP | 9,005,474 32.900% | 784,899 (+9.55%) | View |
2020-02-14 3:59 pm Sale | 13G | LA JOLLA PHARMACEUTICAL CO LJPC | PERCEPTIVE ADVISORS LLC | 0 0.000% | -2,253,376 (Position Closed) | View |